288 related articles for article (PubMed ID: 26313361)
1. Impact of Genomics Platform and Statistical Filtering on Transcriptional Benchmark Doses (BMD) and Multiple Approaches for Selection of Chemical Point of Departure (PoD).
Webster AF; Chepelev N; Gagné R; Kuo B; Recio L; Williams A; Yauk CL
PLoS One; 2015; 10(8):e0136764. PubMed ID: 26313361
[TBL] [Abstract][Full Text] [Related]
2. Recommended approaches in the application of toxicogenomics to derive points of departure for chemical risk assessment.
Farmahin R; Williams A; Kuo B; Chepelev NL; Thomas RS; Barton-Maclaren TS; Curran IH; Nong A; Wade MG; Yauk CL
Arch Toxicol; 2017 May; 91(5):2045-2065. PubMed ID: 27928627
[TBL] [Abstract][Full Text] [Related]
3. Case study on the utility of hepatic global gene expression profiling in the risk assessment of the carcinogen furan.
Jackson AF; Williams A; Recio L; Waters MD; Lambert IB; Yauk CL
Toxicol Appl Pharmacol; 2014 Jan; 274(1):63-77. PubMed ID: 24183702
[TBL] [Abstract][Full Text] [Related]
4. Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water.
Moffat I; Chepelev N; Labib S; Bourdon-Lacombe J; Kuo B; Buick JK; Lemieux F; Williams A; Halappanavar S; Malik A; Luijten M; Aubrecht J; Hyduke DR; Fornace AJ; Swartz CD; Recio L; Yauk CL
Crit Rev Toxicol; 2015 Jan; 45(1):1-43. PubMed ID: 25605026
[TBL] [Abstract][Full Text] [Related]
5. BMDExpress Data Viewer - a visualization tool to analyze BMDExpress datasets.
Kuo B; Francina Webster A; Thomas RS; Yauk CL
J Appl Toxicol; 2016 Aug; 36(8):1048-59. PubMed ID: 26671443
[TBL] [Abstract][Full Text] [Related]
6. Comparison of microarrays and RNA-seq for gene expression analyses of dose-response experiments.
Black MB; Parks BB; Pluta L; Chu TM; Allen BC; Wolfinger RD; Thomas RS
Toxicol Sci; 2014 Feb; 137(2):385-403. PubMed ID: 24194394
[TBL] [Abstract][Full Text] [Related]
7. Toxicogenomics and cancer risk assessment: a framework for key event analysis and dose-response assessment for nongenotoxic carcinogens.
Bercu JP; Jolly RA; Flagella KM; Baker TK; Romero P; Stevens JL
Regul Toxicol Pharmacol; 2010 Dec; 58(3):369-81. PubMed ID: 20801182
[TBL] [Abstract][Full Text] [Related]
8. Automated quantitative dose-response modeling and point of departure determination for large toxicogenomic and high-throughput screening data sets.
Burgoon LD; Zacharewski TR
Toxicol Sci; 2008 Aug; 104(2):412-8. PubMed ID: 18441342
[TBL] [Abstract][Full Text] [Related]
9. Application of transcriptional benchmark dose values in quantitative cancer and noncancer risk assessment.
Thomas RS; Clewell HJ; Allen BC; Wesselkamper SC; Wang NC; Lambert JC; Hess-Wilson JK; Zhao QJ; Andersen ME
Toxicol Sci; 2011 Mar; 120(1):194-205. PubMed ID: 21097997
[TBL] [Abstract][Full Text] [Related]
10. Regulatory cancer risk assessment based on a quick estimate of a benchmark dose derived from the maximum tolerated dose.
Gaylor DW; Swirsky Gold L
Regul Toxicol Pharmacol; 1998 Dec; 28(3):222-5. PubMed ID: 10049793
[TBL] [Abstract][Full Text] [Related]
11. Toxicogenomic assessment of liver responses following subchronic exposure to furan in Fischer F344 rats.
Dong H; Gill S; Curran IH; Williams A; Kuo B; Wade MG; Yauk CL
Arch Toxicol; 2016 Jun; 90(6):1351-67. PubMed ID: 26194646
[TBL] [Abstract][Full Text] [Related]
12. Nano-risk Science: application of toxicogenomics in an adverse outcome pathway framework for risk assessment of multi-walled carbon nanotubes.
Labib S; Williams A; Yauk CL; Nikota JK; Wallin H; Vogel U; Halappanavar S
Part Fibre Toxicol; 2016 Mar; 13():15. PubMed ID: 26979667
[TBL] [Abstract][Full Text] [Related]
13. Temporal concordance between apical and transcriptional points of departure for chemical risk assessment.
Thomas RS; Wesselkamper SC; Wang NC; Zhao QJ; Petersen DD; Lambert JC; Cote I; Yang L; Healy E; Black MB; Clewell HJ; Allen BC; Andersen ME
Toxicol Sci; 2013 Jul; 134(1):180-94. PubMed ID: 23596260
[TBL] [Abstract][Full Text] [Related]
14. A Rat Liver Transcriptomic Point of Departure Predicts a Prospective Liver or Non-liver Apical Point of Departure.
Johnson KJ; Auerbach SS; Costa E
Toxicol Sci; 2020 Jul; 176(1):86-102. PubMed ID: 32384157
[TBL] [Abstract][Full Text] [Related]
15. Comparing next-generation sequencing and microarray technologies in a toxicological study of the effects of aristolochic acid on rat kidneys.
Su Z; Li Z; Chen T; Li QZ; Fang H; Ding D; Ge W; Ning B; Hong H; Perkins RG; Tong W; Shi L
Chem Res Toxicol; 2011 Sep; 24(9):1486-93. PubMed ID: 21834575
[TBL] [Abstract][Full Text] [Related]
16. A toxicogenomic approach for the risk assessment of the food contaminant acetamide.
Nault R; Bals B; Teymouri F; Black MB; Andersen ME; McMullen PD; Krishnan S; Kuravadi N; Paul N; Kumar S; Kannan K; Jayachandra KC; Alagappan L; Patel BD; Bogen KT; Gollapudi BB; Klaunig JE; Zacharewski TR; Bringi V
Toxicol Appl Pharmacol; 2020 Feb; 388():114872. PubMed ID: 31881176
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of benchmark dose methodology for non-cancer continuous-data health effects in animals due to exposures to dioxin (TCDD).
Gaylor DW; Aylward LL
Regul Toxicol Pharmacol; 2004 Aug; 40(1):9-17. PubMed ID: 15265602
[TBL] [Abstract][Full Text] [Related]
18. RNA-Seq versus oligonucleotide array assessment of dose-dependent TCDD-elicited hepatic gene expression in mice.
Nault R; Fader KA; Zacharewski T
BMC Genomics; 2015 May; 16(1):373. PubMed ID: 25958198
[TBL] [Abstract][Full Text] [Related]
19. Inter-laboratory study of human in vitro toxicogenomics-based tests as alternative methods for evaluating chemical carcinogenicity: a bioinformatics perspective.
Herwig R; Gmuender H; Corvi R; Bloch KM; Brandenburg A; Castell J; Ceelen L; Chesne C; Doktorova TY; Jennen D; Jennings P; Limonciel A; Lock EA; McMorrow T; Phrakonkham P; Radford R; Slattery C; Stierum R; Vilardell M; Wittenberger T; Yildirimman R; Ryan M; Rogiers V; Kleinjans J
Arch Toxicol; 2016 Sep; 90(9):2215-2229. PubMed ID: 26525393
[TBL] [Abstract][Full Text] [Related]
20. Benchmark dose modeling of transcriptional data: a systematic approach to identify best practices for study designs used in radiation research.
Stainforth R; Vuong N; Adam N; Kuo B; Wilkins RC; Yauk C; Beheshti A; Chauhan V
Int J Radiat Biol; 2022; 98(12):1832-1844. PubMed ID: 35939275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
